MAGENTA THERAPEUTICS INC (MGTA) Stock Income Statement
USA - NASDAQ:MGTA - US55910K1088 - Common Stock
0.6996 USD
-0.06 (-7.74%)
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 58.57M | 80.90M | 74.69M | 78.70M | 82.97M | |||
| Research and Development | 35.13M | 55.14M | 46.77M | 50.62M | 59.21M | |||
| Selling, General, and Administrative Expenses | 23.44M | 25.76M | 27.93M | 28.09M | 23.76M | |||
| Operating Income | -58.57M | -80.90M | -74.69M | -78.70M | -82.97M | |||
| Interest Income/Expense | 9.79M | 4.44M | 3.56M | 3.77M | 6.20M | |||
| Income Before Taxes | -68.69M | -76.46M | -71.14M | -74.94M | -76.77M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -68.69M | -76.46M | -71.14M | -74.94M | -76.77M | |||
| EBITDA | N/A | -78.98M | -72.67M | -76.72M | -81.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -14.16 | -1.29 | -1.29 | -1.71 | -33.18 | |||
| Non GAAP EPS | -1.14 | -1.29 | -1.31 | -1.74 | -2.05 | |||
| Statistics | ||||||||
All data in USD